TRex Bio, Inc. (TRXB) stock
TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$14.10−0.15 (-1.05%)
Close on Nov 12, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $14.25
- Open
- $14.01
- Day's range
- $13.40 – $14.20
- Volume
- 45,615
- Average volume (20 days)
- 90,289
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | TRXB | S&P 500 | Difference | TRXB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.5% | -2.7% | +3.2 pts |
TRex Bio stock: common questions
What is TRex Bio's stock price?
TRXB closed at $14.10 on Nov 12, 2026, down 1.05% on the day.
Does TRex Bio pay a dividend?
No. TRex Bio has not paid a cash dividend over the last twelve months.
Who are TRex Bio's competitors?
Companies most similar to TRex Bio by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?